G01N 2333/48
Nerve growth factor [ngf]
Official title: Nerve growth factor [NGF]
G01N2333/48 (Nerve growth factor [ngf]) appears on 34 US grants and 51 published applications in this corpus.
Search patents in G01N- Granted patents
- 34
- Published applications
- 51
- Assignees
- 49
- Inventors
- 127
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 0 | 3 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 4 | 2 |
| 2010 | 2 | 2 |
| 2011 | 1 | 6 |
| 2012 | 2 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 2 | 3 |
| 2016 | 0 | 6 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 2 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 2 |
| 2024 | 1 | 6 |
| 2025 | 0 | 3 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-NGF antibody and antigen-binding fragment thereof, preparation method, and application thereof7 Apr 2026US 12,595,298 B2Xiyuan Anjian Medicine (Shanghai) Co., Ltd
- Methods of detecting and treating cerebral aneurysms17 Feb 2026US 12,553,904 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- TrkA antibody and application thereof3 Sep 2024US 12,077,591 B24B Technologies (Suzhou) Limited
- Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASD22 Aug 2023US 11,733,243 B2Indiana University Research and Technology Corporation
- Monoclonal antibody against nerve growth factor, and encoding gene and use thereof20 Jun 2023US 11,680,095 B2Akeso Biopharma, Inc.
- Methods of detecting and treating cerebral aneurysms19 Feb 2026US 2026/0049998 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods of detecting and treating cerebral aneurysms13 Nov 2025US 2025/0347700 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Monoclonal antibody against nerve growth factor, and encoding gene and use thereof10 Jul 2025US 2025/0223346 A1Akeso Biopharma, Inc.
- Trka antibody and application thereof13 Mar 2025US 2025/0084173 A14B Technologies (Beijing) Co., Limited
- Trka antibody and application thereof26 Dec 2024US 2024/0425605 A14B Technologies (Suzhou) Limited
Most cited
By later US patents
- Prostaglandin E2 dual variable domain immunoglobulins and uses thereof85US 8,822,645 B2AbbVie Inc. · 2014
- Identification of ligands by selective amplification of cells transfected with receptors82US 5,707,798 ANovo Nordisk A/S · 1998
- Identification of ligands by selective amplification of cells transfected with receptors52US 5,912,132 AACADIA Pharmaceuticals Inc. · 1999
- Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors52US 8,106,167 B2Amgen Inc. · 2012
- Identification of ligands by selective amplification of cells transfected with receptors51US 5,955,281 AACADIA Pharmaceuticals Inc. · 1999